L Cordero1, C A Nankervis, R W Oshaughnessy, S A Koff, P J Giannone. 1. Department of Pediatrics, Division of Neonatal-Perinatal Medicine, College of Medicine, The Ohio State University, Columbus, OH 43210-1228, USA. leandro.cordero@osumc.edu
Abstract
OBJECTIVE: To examine our experience with ANH and to determine the success of our postnatal follow-up program. STUDY DESIGN: Charts of mothers and infants seen (2004 to 2008) at our Regional Perinatal Center were reviewed retrospectively. ANH was defined during the third trimester by anterior pelvic diameters as follows: mild 7 to 9, moderate 10 to 14 or severe >or=15 mm. Fetuses with multicystic dysplastic kidney (MCDK) were included. RESULT: Screening of approximately 15 000 ultrasound (US) reports identified 268 fetuses with ANH. After prenatal US surveillance, 88 (33%) fetuses had resolved, while 180 (67%) required postnatal follow-up. These 180 fetuses were diagnosed with mild 38 (21%), moderate 83 (46%) and severe 19 (11%) ANH, uni or bilateral hydroureters 12 (7%), MCDK 19 (10%) and miscellaneous 9 (5%). Postnatal follow-up was successfully established for 75% of infants with hydroureters, 68% for those with MCDK and for 37% of infants with mild, 53% with moderate and 58% with severe ANH. Factors commonly known to influence compliance were not found more frequently among the 91 infants who were lost to follow-up. The only positive predictor for postnatal follow-up was a prenatal consultation with the pediatric urologist. CONCLUSION: Our antepartum program for diagnosis of ANH is accessible and efficient; however, there was an unacceptably high number of infants lost to follow-up. The absence of traditional barriers for compliance highlights the need to explore new ways of improving postnatal follow-up of infants with ANH.
OBJECTIVE: To examine our experience with ANH and to determine the success of our postnatal follow-up program. STUDY DESIGN: Charts of mothers and infants seen (2004 to 2008) at our Regional Perinatal Center were reviewed retrospectively. ANH was defined during the third trimester by anterior pelvic diameters as follows: mild 7 to 9, moderate 10 to 14 or severe >or=15 mm. Fetuses with multicystic dysplastic kidney (MCDK) were included. RESULT: Screening of approximately 15 000 ultrasound (US) reports identified 268 fetuses with ANH. After prenatal US surveillance, 88 (33%) fetuses had resolved, while 180 (67%) required postnatal follow-up. These 180 fetuses were diagnosed with mild 38 (21%), moderate 83 (46%) and severe 19 (11%) ANH, uni or bilateral hydroureters 12 (7%), MCDK 19 (10%) and miscellaneous 9 (5%). Postnatal follow-up was successfully established for 75% of infants with hydroureters, 68% for those with MCDK and for 37% of infants with mild, 53% with moderate and 58% with severe ANH. Factors commonly known to influence compliance were not found more frequently among the 91 infants who were lost to follow-up. The only positive predictor for postnatal follow-up was a prenatal consultation with the pediatric urologist. CONCLUSION: Our antepartum program for diagnosis of ANH is accessible and efficient; however, there was an unacceptably high number of infants lost to follow-up. The absence of traditional barriers for compliance highlights the need to explore new ways of improving postnatal follow-up of infants with ANH.